CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug attack on advanced liver cancer enters testing
Disease control Recruiting nowThis study is testing a new combination of three drugs for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if adding a new oral drug, Irpagratinib, to two existing drugs (Atezolizumab and Bevacizumab) is safe and can help control the cancer…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New targeted chemo tested for inoperable liver cancer
Disease control Recruiting nowThis study is testing a targeted chemotherapy treatment for liver cancer in patients who also have liver scarring (cirrhosis) and cannot have surgery. Doctors inject a chemotherapy drug mixed with an oily agent directly into the liver's blood supply to try to control the tumor. T…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for advanced liver cancer patients in pfizer trial
Disease control Recruiting nowThis study is testing a new drug called PF-08634404 to see if it is safe and effective for treating advanced liver cancer that cannot be removed by surgery. It will be given alone or combined with another drug (ipilimumab) to 138 adults who have not had other whole-body treatment…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug combo aims to keep liver cancer at bay after radiation
Disease control Recruiting nowThis study is testing if adding a drug called tislelizumab after radiation or other local treatments helps people with liver cancer that cannot be surgically removed. The goal is to see if this combination treatment can keep the cancer from growing or spreading for a longer perio…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Major study aims to find best test to catch liver cancer early
Diagnosis Recruiting nowThis large national trial aims to find the best method for early liver cancer detection in people at high risk. It will compare the current standard approach (an ultrasound plus a blood test) against a newer blood test alone. The goal is to see which method is more effective at f…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Diagnosis
Last updated Mar 04, 2026 15:29 UTC
-
VA launches major trial to find best liver cancer screening method
Prevention Recruiting nowThis study aims to find the best screening method to detect liver cancer early in people with cirrhosis. Researchers will compare standard ultrasound with a faster MRI scan, both done every six months, to see which finds cancer sooner. The goal is to catch cancer at earlier stage…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Scientists track how aging affects liver cancer treatment
Knowledge-focused Recruiting nowThis study aims to better understand how liver cancer affects older adults and how they respond to treatments. Researchers will observe 84 participants with advanced liver cancer, focusing on those aged 65 and older. The goal is to identify treatment patterns and side effects to …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
New lab test aims to match cancer patients with the right drug faster
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to see if it can predict which cancer treatments will work best for a patient. Researchers will take a sample of a patient's tumor cells from a fluid or tissue biopsy and test how the cells react to different drugs in the lab. The goa…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC